43 engineering-computation "https:" "https:" "https:" "https:" "https:" "https:" "ETH Zürich" PhD positions at Leibniz
Sort by
Refine Your Search
-
, computer science, medicine, pharmacology, and physics. ISAS is a member of the Leibniz Association and is publicly funded by the Federal Republic of Germany and its federal states. At our location in
-
and technologies. The institute employs an average of 500 people from over 40 nations and, in addition to its scientific tasks, is dedicated to promoting young scientists and engineers. Further
-
Leibniz Institute of Plant Biochemistry (IPB) in Halle (Saale), Germany, where we are offering a fully-funded PhD position within the DFG Priority Programme SPP2363: “Molecular Machine Learning”. About the
-
environment. The candidate will be given the opportunity to develop a doctoral thesis with extensive support through the RTG2413 (www.synage.de ) and the CBBS graduate program (gp.cbbs.eu ). Your profile
-
. or comparable) in (bio-)physics, (bio-)chemistry, materials science, mechanical/(bio)chemical engineering or similar fields. Highly motivated and team-oriented Passion for multidisciplinary research and eagerness
-
/biomedical engineering or of relevant scientific field A solid background in machine learning Extensive experience with either computer vision or image analysis Good knowledge of deep learning packages
-
facilities and state-of-the-art infrastructure to study the chemical diversity, biochemical interactions and biological functions of small natural product molecules in and from plants and fungi (https
-
. or comparable) in (bio-)physics, (bio-)chemistry, materials science, mechanical/(bio)chemical engineering or similar fields. Highly motivated and team-oriented Passion for multidisciplinary research and eagerness
-
The Leibniz Institute for Prevention Research and Epidemiology – BIPS in Bremen, Germany, invites applications for its three-year PhD program starting October 1, 2026. BIPS, a leading center for
-
CANCER (F/M/D) Starting on May 1st, 2026 (with flexibility). We have pioneered the development of synthetic tumor immune microenvironments, engineered from artificial cells that mimic immune functions